ShanghaiTech University Knowledge Management System
Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes | |
2022-10-27 | |
发表期刊 | CELL COMMUNICATION AND SIGNALING |
EISSN | 1478-811X |
卷号 | 20期号:1 |
发表状态 | 已发表 |
DOI | 10.1186/s12964-022-00985-2 |
摘要 | Background: Myelodysplastic syndrome (MDS) is a clonal disease of hematopoietic cells, characterized by hematopoietic cell hematopoiesis and a high risk of transformation into acute myeloid leukemia (AML). Although the underlying mechanism is unclear, MDS is often associated with immune system disorders, especially cellular immune abnormalities. We analyzed the number of lymphocyte subsets by flow cytometry assay and explored the alteration of lymphocyte subsets in MDS. Methods: Healthy controls, inpatients with primary MDS and patients with AML diagnosed from January 2017 to July 2021 were included. Flow cytometry assays were used to study lymphocyte subsets obtained from the bone marrow of the participants as well as changes in natural killer (NK) cell function. One-way analysis of variance and Student’s t-test were used to analyze the data. Results: We found a reduction in the number and function of NK cells in patients with MDS. By further measuring the activating and inhibitory receptors on the surface of NK cells, we found that the T cell immunoglobulin and ITIM domain (TIGIT) was the highest expressed marker on NK cells. Additionally, the expression of CD155, which is the ligand of TIGIT, was significantly higher than expressions of CD112 and CD113 on bone marrow mesenchymal stem cells (BMSCs). Conclusions: The co-culture results of BMSCs and NK cells demonstrated that BMSCs regulate NK cells through the TIGIT/CD155 interaction, indicating that NK cells play a vital role in MDS progression. BMSCs regulate the function of NK cells via TIGIT/CD155. |
关键词 | Bone marrow mesenchymal stem cells Immune system Myelodysplastic syndrome Natural killer cells T cell immunoglobulin and ITIM domain |
URL | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
Scopus 记录号 | 2-s2.0-85140859785 |
来源库 | Scopus |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/243356 |
专题 | 免疫化学研究所_特聘教授组_张宏恺组 |
通讯作者 | Fu, Rong |
作者单位 | 1.Department of Hematology,Tianjin Medical University General Hospital,Tianjin,China 2.Yuncheng Central Hospital,Yuncheng,Shanxi,China 3.Shanghai Institute for Advanced Immunochemical Studies,ShanghaiTech University,Shanghai,201210,China 4.State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences,Nankai University,Tianjin,94 Weijin Road,300071,China |
推荐引用方式 GB/T 7714 | Liu, Zhaoyun,Guo, Yixuan,Huang, Lei,et al. Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes[J]. CELL COMMUNICATION AND SIGNALING,2022,20(1). |
APA | Liu, Zhaoyun.,Guo, Yixuan.,Huang, Lei.,Jia, Yue.,Liu, Hui.,...&Fu, Rong.(2022).Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes.CELL COMMUNICATION AND SIGNALING,20(1). |
MLA | Liu, Zhaoyun,et al."Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes".CELL COMMUNICATION AND SIGNALING 20.1(2022). |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。